DEFERASIROX AND DEFEROXAMINE COMBINATION THERAPY: A CASE OF MANAGEMENT OF IRON OVERLOAD IN MYELODYSPLASTIC SYNDROME IN AN HEPATOPATHIC PATIENT.

被引：0
|
作者：
Cerchione, C. [1 ]
Cerciello, G. [1 ]
Della Pepa, R. [1 ]
Matarazzo, M. [1 ]
Alfinito, F. [1 ]
Pane, F. [1 ]
机构：
[1] Univ Federico II, Naples, Italy
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1847
引用
收藏
页码：713 / 713
页数：1
相关论文
共 50 条
  • [31] Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome
    Takamasa Nishiuchi
    Yuichi Okutani
    Toshikazu Fujita
    Kazuya Yoshida
    Hiroaki Ohnishi
    Reiji Haba
    International Journal of Hematology, 2010, 91 : 333 - 335
  • [32] SHORT-TERM HIGH-DOSE INTRAVENOUS DEFEROXAMINE AS COMBINATION THERAPY FOR REDUCTION OF IRON IN PATIENTS WITH PERSISTENT IRON OVERLOAD
    Lilla, Stephanie Fritch
    Hart, Nicole
    Appert, Kristen
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [33] Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies
    Voskaridou, Ersi
    Christoulas, Dimitrios
    Terpos, Evangelos
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (05) : 654 - 656
  • [34] Deferasirox combination with eltrombopag shows anti-myelodysplastic syndrome effects by enhancing iron deprivation-related apoptosis
    Huang, Lei
    Tian, Mengyue
    Liu, Zhaoyun
    Liu, Chunyan
    Fu, Rong
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (04) : 953 - 962
  • [35] Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: A brief review
    Guariglia, Roberto
    Martorelli, Maria Carmen
    Villani, Oreste
    Pietrantuono, Giuseppe
    Mansueto, Giovanna
    D'Auria, Fiorella
    Grieco, Vitina
    Bianchino, Gabriella
    Lerose, Rosa
    Bochicchio, Giovanni Battista
    Musto, Pellegrino
    LEUKEMIA RESEARCH, 2011, 35 (05) : 566 - 570
  • [36] Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications
    Remacha, Angel F.
    Arrizabalaga, Beatriz
    Villegas, Ana
    Soledad Duran, Maria
    Hermosin, Lourdes
    de Paz, Raquel
    Garcia, Marta
    Diez Campelo, Maria
    Sanz, Guillermo
    ANNALS OF HEMATOLOGY, 2015, 94 (05) : 779 - 787
  • [37] Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications
    Ángel F. Remacha
    Beatriz Arrizabalaga
    Ana Villegas
    María Soledad Durán
    Lourdes Hermosín
    Raquel de Paz
    Marta Garcia
    Maria Diez Campelo
    Guillermo Sanz
    Annals of Hematology, 2015, 94 : 779 - 787
  • [38] Effects of iron chelation therapy on allogeneic hematopoietic stem cell transplantation in myelodysplastic syndrome patients with iron overload
    顾彩红
    China Medical Abstracts (Internal Medicine), 2016, 33 (02) : 54 - 55
  • [39] The impact of chelation therapy on survival in transfusional iron overload: a meta-analysis of myelodysplastic syndrome
    Mainous, Arch G., III
    Tanner, Rebecca J.
    Hulihan, Mary M.
    Amaya, Mirna
    Coates, Thomas D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (05) : 720 - 723
  • [40] Deferasirox-Deferoxa ine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload (HYPERION)
    Aydinok, Yesim
    Kattamis, Antonis
    Cappellini, M. Domenica
    El-Beshlawy, Amal
    Origa, Raffaella
    Elalfy, Mohsen
    Kilinc, Yurdanur
    Perrotta, Silverio
    Karakas, Zeynep
    Viprakasit, Vip
    Habr, Dany
    Wegener, Antje
    Shen, Junwu
    Porter, John B.
    BLOOD, 2013, 122 (21)
12345